Share your videos with the world

Sign Up | Log In | Help  

   
 
Search // fda
Results 61-62 of 62 for ' fda ' (0 seconds)
October is National Seafood Month and a time to highlight the importance of fish and shellfish as part of a healthful diet. As with any food, safe handling of seafood is essential to reducing the risk of foodborne illness (often called food poisoning). Learn more at: http://www.fda.gov/Food/FoodborneIllnessContaminants/BuyStoreServeSafeFood/ucm077331.htm Fresh and Frozen Seafood: Selecting and Serving it Safely The U.S. Food and Drug Administration (FDA) reminds you to follow these basic safety tips for buying, storing, and preparing fish and shellfish. To view the multimedia release go to: http://www.multivu.com/players/English/7594351-fda-seafood-safety/
Categories // Miscellaneous 
Added: 3576 days ago by MultiVuVideos
Runtime: 3m37s | Views: 1382 | Comments: 0
Not yet rated
 

 

 

Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best. Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo. To view the multimedia release go to: http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Categories // Miscellaneous 
Added: 3555 days ago by MultiVuVideos
Runtime: 3m40s | Views: 1002 | Comments: 0
Not yet rated
 

 

 

Page 6 of 6  |  Go to page     |  ««FIRST «Previous  



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2026 ClipMoon.com. All rights reserved.